Medical experts clash over use of 'danger' schizophrenia drug

Caution is killing patients earlier, claims new study by doctors in The Lancet

Excessive caution by drug regulators in Britain and abroad has contributed to the deaths of thousands of patients with severe mental illness, say doctors.

Patients with schizophrenia have been condemned to second-rate treatments, often for years, which are less effective at controlling the illness and preventing suicide because of misplaced anxiety about the safety of the most effective drug, clozapine. The pharmaceutical industry also bears a share of the responsibility for restricting the use of clozapine because it promotes more expensive but less effective drugs which bring it more profit, the doctors say today in The Lancet.

A new study shows that clozapine, always thought to be a dangerous drug, actually cut the death rate among patients with schizophrenia by 26 per cent, compared with the standard treatment. But the finding was challenged by British experts who said the serious side effects linked with clozapine meant patients needed close monitoring and it would always be a drug of last resort.

Worldwide, millions of patients with severe mental illness are treated with antipsychotic drugs to control their delusions and hallucinations. Evidence shows that, on average, they die 25 years earlier than those in the general population, partly because of increased smoking and obesity, but also by suicide.

Professor Jari Tiihonen, of the University of Kuopio, Finland, and colleagues say that the introduction of newer antipsychotics, including clozapine, in the 1990s is widely thought to have increased deaths among patients with schizophrenia. But an analysis of the data shows that, while some drugs were associated with an increased risk, clozapine lowered the risk of dying the most, despite being the drug most closely restricted by the authorities because of safety concerns.

Clozapine can cause agranulocytoisis, which destroys the white blood cells and causes falls in blood pressure, convulsions, diabetes and weight gain. Patients must have regular blood tests while taking it. Professor Tiihonen said: "In all western countries, clozapine is recommended for use only as a second-line drug, after at least two other anti-psychotics have been tried and failed. I would like to see it considered for first line use. Doctors and the [drug regulatory] authorities are too cautious.

"Patients with schizophrenia may suffer delusions and hallucinations for years while doctors try different anti-psychotics before they get to clozapine. They are not active enough in getting patients into remission. They should try clozapine earlier." In a study two years ago in the British Medical Journal, Professor Tiihonen showed that patients were less likely to stop taking taking clozapine than other anti-psychotics, despite its side effects. "Patients are more willing to use it, probably because it is effective," he said.

But Professor Tim Kendall, deputy director of the Royal College of Psychiatrist's research unit, said a major study of clozapine in China showed it was no more effective than the older antipsychotic chlorpromazine. "The evidence for first-line use is not there. Clozapine is associated with a much broader range of side-effects. It seems to have a different effect and works better in people who have tried other drugs which have failed. These findings should be interpreted with real caution."

Les Iversen, professor of pharmacology at the University of Oxford, said: "I cannot agree that clozapine should be the drug of first choice for treating schizophrenia. This is because the adverse side effect of agranulocytosis is serious and can be life-threatening. It occurs in about 2 per cent of patients, and all patients require tedious and costly monitoring, initially weekly, later monthly to detect this side-effect. For this reason, clozapine has become a drug of last resort, and will probably remain so."

Life and Style
ebookNow available in paperback
ebookA delicious collection of 50 meaty main courses
Latest stories from i100
Have you tried new the Independent Digital Edition apps?

ES Rentals

    Independent Dating

    By clicking 'Search' you
    are agreeing to our
    Terms of Use.

    iJobs Job Widget
    iJobs General

    Recruitment Genius: New Business Development Manager / Sales - UK New Business

    £24000 - £36000 per annum: Recruitment Genius: Join a fast growing, UK based I...

    MBDA UK Ltd: Mission Planning and Control Solutions Systems Engineer

    Competitive salary & benefits: MBDA UK Ltd: What’s the opportunity? A pro-act...

    MBDA UK Ltd: System Design Capability

    Competitive salary & benefits: MBDA UK Ltd: What’s the opportunity? The small...

    Recruitment Genius: Time Served Fabricator / Welders - Immediate Start

    £25000 - £35000 per annum: Recruitment Genius: Fabricator welder required for ...

    Day In a Page

    Sepp Blatter resignation: The beginning of Fifa's long road to reform?

    Does Blatter's departure mean Fifa will automatically clean up its act?

    Don't bet on it, says Tom Peck
    Charles Kennedy: The baby of the House who grew into a Lib Dem giant

    The baby of the House who grew into a Lib Dem giant

    Charles Kennedy was consistently a man of the centre-left, dedicated to social justice, but was also a champion of liberty and an opponent of the nanny-state, says Baroness Williams
    Syria civil war: The harrowing testament of a five-year-old victim of this endless conflict

    The harrowing testament of a five-year-old victim of Syria's endless civil war

    Sahar Qanbar lost her mother and brother as civilians and government soldiers fought side by side after being surrounded by brutal Islamist fighters. Robert Fisk visited her
    The future of songwriting: How streaming is changing everything we know about making music

    The future of songwriting

    How streaming is changing everything we know about making music
    William Shemin and Henry Johnson: Jewish and black soldiers receive World War I Medal of Honor amid claims of discrimination

    Recognition at long last

    Jewish and black soldiers who fought in WWI finally receive medals after claims of discrimination
    Beating obesity: The new pacemaker which helps over-eaters

    Beating obesity

    The new pacemaker which helps over-eaters
    9 best women's festival waterproofs

    Ready for rain: 9 best women's festival waterproofs

    These are the macs to keep your denim dry and your hair frizz-free(ish)
    Cycling World Hour Record: Nervous Sir Bradley Wiggins ready for pain as he prepares to go distance

    Wiggins worried

    Nervous Sir Bradley ready for pain as he prepares to attempt cycling's World Hour Record
    Liverpool close in on Milner signing

    Liverpool close in on Milner signing

    Reds baulk at Christian Benteke £32.5m release clause
    On your feet! Spending at least two hours a day standing reduces the risk of heart attacks, cancer and diabetes, according to new research

    On your feet!

    Spending half the day standing 'reduces risk of heart attacks and cancer'
    With scores of surgeries closing, what hope is there for the David Cameron's promise of 5,000 more GPs and a 24/7 NHS?

    The big NHS question

    Why are there so few new GPs when so many want to study medicine?
    Big knickers are back: Thongs ain't what they used to be

    Thongs ain't what they used to be

    Big knickers are back
    Thurston Moore interview

    Thurston Moore interview

    On living in London, Sonic Youth and musical memoirs
    In full bloom

    In full bloom

    Floral print womenswear
    From leading man to Elephant Man, Bradley Cooper is terrific

    From leading man to Elephant Man

    Bradley Cooper is terrific